Download
1 / 5
50 likes | 50 Vues
The Rapid Influenza Diagnostic Tests Market Share is estimated to be reaching US$ 1.6 Billion at a CAGR of 8.7% from 2019 to 2029. With advanced digitization driving the healthcare industry, the concept of a u201cglobal villageu201d has become a reality. As such, medical treatment could be sought to transcend the geographical barriers, which would form the focal point of the healthcare industry going forward.
E N D
Rapid Influenza Diagnostic Tests Market Report Id : PMRREP31040 Category : Life Science & Healthcare ©2020 Persistence Market Research, All Rights Reserved
About Persistence Market Research Customized Research Persistence Market Research(Persistence Market Research) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. Persistence Market Research is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Syndicated Research Investment Research Social Media Research Research Capabilities Sector Coverage • Automotive and Transportation • Electronics, Semiconductor, and ICT • Retail and Consumer Products • Industrial Automation and Equipment • Customized Research • Syndicated Research • Investment Research • Social Media Research • Chemicals & Materials • Food and Beverages • Services and Utilities • Energy, Mining, Oil, and Gas Subscription Information For detailed subscription information please contact Website: www.persistencemarketresearch.com For sales queries or new topics email us on: sales@persistencemarketresearch.com
Exhilaration To Be Witnessed By The Rapid Influenza Diagnostic Tests Market Between 2029 At A CAGR Of 8% The Rapid Influenza Diagnostic Tests Market Share is estimated to be reaching US$ 1.6 Billion at a CAGR of 8.7% from 2019 to 2029. With advanced digitization driving the healthcare industry, the concept of a “global village” has become a reality. As such, medical treatment could be sought to transcend the geographical barriers, which would form the focal point of the healthcare industry going forward. Diagnosis of infectious diseases such as influenza is seeing a sea change owing to technological innovations and development of next-generation molecular tests such as Nuclear Acid Amplification Tests (NAATs) and advanced immunoassays. The global rapid influenza diagnostic tests market size will witness robust expansion at over 8% CAGR during the forecast period (2019 – 2029). With the rise in epidemics and pandemics since the last few years, government agencies in some countries are providing funds for development of innovative rapid influenza diagnostic tests. Get Sample Copy of this Report @https://www.persistencemarketresearch.com/samples/31040
Company Profiles • BioFireDiagnostics (bioMerieux, Inc.) • Biosynex S.A. • Cepheid, Inc. • Creative Diagnostics • Focus Diagnostics (DiaSorinSpA) • F. Hoffmann-La Roche • GenMark Diagnostics • Hologic, Inc. • Luminex Corporation • Meridian Bioscience, Inc. • Princeton BioMeditech Corporation • QIAGEN N.V. • Quidel Corporation • Sekisui Diagnostics • Thermo Fisher Scientific, Inc. Access Full Report @ https://www.persistencemarketresearch.com/checkout/31040
